Stergios A. Polyzos*, Antonis Goulas and Paraskevi Papaioannidou Pages 2476 - 2479 ( 4 )
Diabetes, fibrosis, glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic polypeptide, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, obesity, tirzepatide.